-
1
-
-
65349121788
-
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
-
Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, et al. (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10: 459-66.
-
(2009)
Lancet Oncol
, vol.10
, pp. 459-466
-
-
Stupp, R.1
Hegi, M.E.2
Mason, W.P.3
van den Bent, M.J.4
Taphoorn, M.J.5
-
3
-
-
67649084009
-
Targeted therapy for malignant glioma patients: lessons learned and the road ahead
-
Huang TT, Sarkaria SM, Cloughesy TF, Mischel PS, (2009) Targeted therapy for malignant glioma patients: lessons learned and the road ahead. Neurotherapeutics 6: 500-12.
-
(2009)
Neurotherapeutics
, vol.6
, pp. 500-512
-
-
Huang, T.T.1
Sarkaria, S.M.2
Cloughesy, T.F.3
Mischel, P.S.4
-
4
-
-
52149096024
-
PTEN signaling pathways in glioblastoma
-
Koul D, (2008) PTEN signaling pathways in glioblastoma. Cancer Biol Ther 7: 1321-5.
-
(2008)
Cancer Biol Ther
, vol.7
, pp. 1321-1325
-
-
Koul, D.1
-
5
-
-
4944255253
-
Genetic pathways to glioblastoma: a population-based study
-
Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, et al. (2004) Genetic pathways to glioblastoma: a population-based study. Cancer Res 64: 6892-9.
-
(2004)
Cancer Res
, vol.64
, pp. 6892-6899
-
-
Ohgaki, H.1
Dessen, P.2
Jourde, B.3
Horstmann, S.4
Nishikawa, T.5
-
6
-
-
85027927262
-
Association between AKT/mTOR signalling pathway and malignancy grade of human gliomas
-
Li XY, Zhang LQ, Zhang XG, Li X, Ren YB, et al. (2011) Association between AKT/mTOR signalling pathway and malignancy grade of human gliomas. J Neurooncol 103: 453-8.
-
(2011)
J Neurooncol
, vol.103
, pp. 453-458
-
-
Li, X.Y.1
Zhang, L.Q.2
Zhang, X.G.3
Li, X.4
Ren, Y.B.5
-
7
-
-
0036094711
-
Dysregulation of PTEN and protein kinase B is associated with glioma histology and patient survival
-
Ermoian RP, Furniss CS, Lamborn KR, Basila D, Berger MS, et al. (2002) Dysregulation of PTEN and protein kinase B is associated with glioma histology and patient survival. Clin Cancer Res 8: 1100-6.
-
(2002)
Clin Cancer Res
, vol.8
, pp. 1100-1106
-
-
Ermoian, R.P.1
Furniss, C.S.2
Lamborn, K.R.3
Basila, D.4
Berger, M.S.5
-
8
-
-
0032558822
-
Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC
-
Haas-Kogan D, Shalev N, Wong M, Mills G, Yount G, et al. (1998) Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC. Curr Biol 8: 1195-8.
-
(1998)
Curr Biol
, vol.8
, pp. 1195-1198
-
-
Haas-Kogan, D.1
Shalev, N.2
Wong, M.3
Mills, G.4
Yount, G.5
-
9
-
-
77953215319
-
Invasive glioblastoma cells acquire stemness and increased Akt activation
-
Molina JR, Hayashi Y, Stephens C, Georgescu MM, (2010) Invasive glioblastoma cells acquire stemness and increased Akt activation. Neoplasia 12: 453-63.
-
(2010)
Neoplasia
, vol.12
, pp. 453-463
-
-
Molina, J.R.1
Hayashi, Y.2
Stephens, C.3
Georgescu, M.M.4
-
10
-
-
77949452524
-
The PKB/AKT pathway in cancer
-
Carnero A, (2010) The PKB/AKT pathway in cancer. Curr Pharm Des 16: 34-44.
-
(2010)
Curr Pharm Des
, vol.16
, pp. 34-44
-
-
Carnero, A.1
-
11
-
-
33747819801
-
mTOR and cancer: insights into a complex relationship
-
Sabatini DM, (2006) mTOR and cancer: insights into a complex relationship. Nat Rev Cancer 6: 729-34.
-
(2006)
Nat Rev Cancer
, vol.6
, pp. 729-734
-
-
Sabatini, D.M.1
-
12
-
-
0038540963
-
United at last: the tuberous sclerosis complex gene products connect the phosphoinositide 3-kinase/Akt pathway to mammalian target of rapamycin (mTOR) signalling
-
Manning BD, Cantley LC, (2003) United at last: the tuberous sclerosis complex gene products connect the phosphoinositide 3-kinase/Akt pathway to mammalian target of rapamycin (mTOR) signalling. Biochem Soc Trans 31: 573-8.
-
(2003)
Biochem Soc Trans
, vol.31
, pp. 573-578
-
-
Manning, B.D.1
Cantley, L.C.2
-
13
-
-
74949106814
-
Inhibition of mTOR Activates the MAPK Pathway in Glioblastoma Multiforme
-
Albert L, Karsy M, Murali R, Jhanwar-Uniyal M, (2009) Inhibition of mTOR Activates the MAPK Pathway in Glioblastoma Multiforme. Cancer Genomics Proteomics 6: 255-61.
-
(2009)
Cancer Genomics Proteomics
, vol.6
, pp. 255-261
-
-
Albert, L.1
Karsy, M.2
Murali, R.3
Jhanwar-Uniyal, M.4
-
14
-
-
70449457461
-
Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility
-
Gulati N, Karsy M, Albert L, Murali R, Jhanwar-Uniyal M, (2009) Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility. Int J Oncol 35: 731-40.
-
(2009)
Int J Oncol
, vol.35
, pp. 731-740
-
-
Gulati, N.1
Karsy, M.2
Albert, L.3
Murali, R.4
Jhanwar-Uniyal, M.5
-
15
-
-
23844438209
-
Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition
-
Sun SY, Rosenberg LM, Wang X, Zhou Z, Yue P, et al. (2005) Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition. Cancer Res 65: 7052-8.
-
(2005)
Cancer Res
, vol.65
, pp. 7052-7058
-
-
Sun, S.Y.1
Rosenberg, L.M.2
Wang, X.3
Zhou, Z.4
Yue, P.5
-
16
-
-
32944457518
-
mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt
-
O'Reilly KE, Rojo F, She QB, Solit D, Mills GB, et al. (2006) mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. Cancer Res 66: 1500-8.
-
(2006)
Cancer Res
, vol.66
, pp. 1500-1508
-
-
O'Reilly, K.E.1
Rojo, F.2
She, Q.B.3
Solit, D.4
Mills, G.B.5
-
17
-
-
13844312400
-
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
-
Sarbassov DD, Guertin DA, Ali SM, Sabatini DM, (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307: 1098-101.
-
(2005)
Science
, vol.307
, pp. 1098-1101
-
-
Sarbassov, D.D.1
Guertin, D.A.2
Ali, S.M.3
Sabatini, D.M.4
-
18
-
-
3342895823
-
Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton
-
Sarbassov DD, Ali SM, Kim DH, Guertin DA, Latek RR, et al. (2004) Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 14: 1296-302.
-
(2004)
Curr Biol
, vol.14
, pp. 1296-1302
-
-
Sarbassov, D.D.1
Ali, S.M.2
Kim, D.H.3
Guertin, D.A.4
Latek, R.R.5
-
19
-
-
77954235821
-
Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy
-
Sparks CA, Guertin DA, (2010) Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy. Oncogene 29: 3733-44.
-
(2010)
Oncogene
, vol.29
, pp. 3733-3744
-
-
Sparks, C.A.1
Guertin, D.A.2
-
20
-
-
37549048521
-
mTORC2 activity is elevated in gliomas and promotes growth and cell motility via overexpression of rictor
-
Masri J, Bernath A, Martin J, Jo OD, Vartanian R, et al. (2007) mTORC2 activity is elevated in gliomas and promotes growth and cell motility via overexpression of rictor. Cancer Res 67: 11712-20.
-
(2007)
Cancer Res
, vol.67
, pp. 11712-11720
-
-
Masri, J.1
Bernath, A.2
Martin, J.3
Jo, O.D.4
Vartanian, R.5
-
21
-
-
0025790916
-
Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo
-
Ekstrand AJ, James CD, Cavenee WK, Seliger B, Pettersson RF, et al. (1991) Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res 51: 2164-72.
-
(1991)
Cancer Res
, vol.51
, pp. 2164-2172
-
-
Ekstrand, A.J.1
James, C.D.2
Cavenee, W.K.3
Seliger, B.4
Pettersson, R.F.5
-
22
-
-
34250877865
-
Genetic pathways to primary and secondary glioblastoma
-
Ohgaki H, Kleihues P, (2007) Genetic pathways to primary and secondary glioblastoma. Am J Pathol 170: 1445-53.
-
(2007)
Am J Pathol
, vol.170
, pp. 1445-1453
-
-
Ohgaki, H.1
Kleihues, P.2
-
23
-
-
33846218204
-
Epidermal growth factor receptor - mediated signal transduction in the development and therapy of gliomas
-
Nicholas MK, Lukas RV, Jafri NF, Faoro L, Salgia R, (2006) Epidermal growth factor receptor- mediated signal transduction in the development and therapy of gliomas. Clin Cancer Res 12: 7261-70.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 7261-7270
-
-
Nicholas, M.K.1
Lukas, R.V.2
Jafri, N.F.3
Faoro, L.4
Salgia, R.5
-
24
-
-
33947681747
-
The epidermal growth factor receptor in malignant gliomas: pathogenesis and therapeutic implications
-
Nakamura JL, (2007) The epidermal growth factor receptor in malignant gliomas: pathogenesis and therapeutic implications. Expert Opin Ther Targets 11: 463-72.
-
(2007)
Expert Opin Ther Targets
, vol.11
, pp. 463-472
-
-
Nakamura, J.L.1
-
25
-
-
73949083511
-
Oncogenic EGFR signaling networks in glioma
-
Huang PH, Xu AM, White FM, (2009) Oncogenic EGFR signaling networks in glioma. Sci Signal 2: re6.
-
(2009)
Sci Signal
, vol.2
-
-
Huang, P.H.1
Xu, A.M.2
White, F.M.3
-
26
-
-
77956868654
-
Epidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistance
-
Hatanpaa KJ, Burma S, Zhao D, Habib AA, (2010) Epidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistance. Neoplasia 12: 675-84.
-
(2010)
Neoplasia
, vol.12
, pp. 675-684
-
-
Hatanpaa, K.J.1
Burma, S.2
Zhao, D.3
Habib, A.A.4
-
27
-
-
0031961980
-
Constitutive activation of phosphatidylinositol 3-kinase by a naturally occurring mutant epidermal growth factor receptor
-
Moscatello DK, Holgado-Madruga M, Emlet DR, Montgomery RB, Wong AJ, (1998) Constitutive activation of phosphatidylinositol 3-kinase by a naturally occurring mutant epidermal growth factor receptor. J Biol Chem 273: 200-6.
-
(1998)
J Biol Chem
, vol.273
, pp. 200-206
-
-
Moscatello, D.K.1
Holgado-Madruga, M.2
Emlet, D.R.3
Montgomery, R.B.4
Wong, A.J.5
-
28
-
-
14444288522
-
The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling
-
Huang HS, Nagane M, Klingbeil CK, Lin H, Nishikawa R, et al. (1997) The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling. J Biol Chem 272: 2927-35.
-
(1997)
J Biol Chem
, vol.272
, pp. 2927-2935
-
-
Huang, H.S.1
Nagane, M.2
Klingbeil, C.K.3
Lin, H.4
Nishikawa, R.5
-
29
-
-
77957937844
-
Targeting SRC in glioblastoma tumors and brain metastases: rationale and preclinical studies
-
Ahluwalia MS, de Groot J, Liu WM, Gladson CL, (2010) Targeting SRC in glioblastoma tumors and brain metastases: rationale and preclinical studies. Cancer Lett 298: 139-49.
-
(2010)
Cancer Lett
, vol.298
, pp. 139-149
-
-
Ahluwalia, M.S.1
de Groot, J.2
Liu, W.M.3
Gladson, C.L.4
-
30
-
-
67651154339
-
Therapeutic inhibition of the epidermal growth factor receptor in high-grade gliomas: where do we stand?
-
Karpel-Massler G, Schmidt U, Unterberg A, Halatsch ME, (2009) Therapeutic inhibition of the epidermal growth factor receptor in high-grade gliomas: where do we stand? Mol Cancer Res 7: 1000-12.
-
(2009)
Mol Cancer Res
, vol.7
, pp. 1000-1012
-
-
Karpel-Massler, G.1
Schmidt, U.2
Unterberg, A.3
Halatsch, M.E.4
-
31
-
-
33847359256
-
Targeting malignant glioma survival signalling to improve clinical outcomes
-
Wong ML, Kaye AH, Hovens CM, (2007) Targeting malignant glioma survival signalling to improve clinical outcomes. J Clin Neurosci 14: 301-8.
-
(2007)
J Clin Neurosci
, vol.14
, pp. 301-308
-
-
Wong, M.L.1
Kaye, A.H.2
Hovens, C.M.3
-
32
-
-
2542561420
-
Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer
-
Zhang Y, Zhang YF, Bryant J, Charles A, Boado RJ, et al. (2004) Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer. Clin Cancer Res 10: 3667-77.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 3667-3677
-
-
Zhang, Y.1
Zhang, Y.F.2
Bryant, J.3
Charles, A.4
Boado, R.J.5
-
33
-
-
12344269275
-
RNA interference and nonviral targeted gene therapy of experimental brain cancer
-
Boado RJ, (2005) RNA interference and nonviral targeted gene therapy of experimental brain cancer. NeuroRx 2: 139-50.
-
(2005)
NeuroRx
, vol.2
, pp. 139-150
-
-
Boado, R.J.1
-
34
-
-
66249119716
-
siRNA-mediated integrin-linked kinase suppression: nonspecific effects of siRNA/cationic liposome complexes trigger changes in the expression of phosphorylated-AKT and mTOR independently of ILK silencing
-
Verreault M, Bally MB, (2009) siRNA-mediated integrin-linked kinase suppression: nonspecific effects of siRNA/cationic liposome complexes trigger changes in the expression of phosphorylated-AKT and mTOR independently of ILK silencing. Oligonucleotides 19: 129-40.
-
(2009)
Oligonucleotides
, vol.19
, pp. 129-140
-
-
Verreault, M.1
Bally, M.B.2
-
35
-
-
79960455176
-
Development of glioblastoma cell lines expressing red fluorescence for non-invasive live imaging of intracranial tumors
-
Verreault M, Strutt D, Masin D, Fink D, Gill R, et al. (2011) Development of glioblastoma cell lines expressing red fluorescence for non-invasive live imaging of intracranial tumors. Anticancer Res 31: 2161-71.
-
(2011)
Anticancer Res
, vol.31
, pp. 2161-2171
-
-
Verreault, M.1
Strutt, D.2
Masin, D.3
Fink, D.4
Gill, R.5
-
36
-
-
63849225752
-
Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors
-
Wakimoto H, Kesari S, Farrell CJ, Curry WT Jr, Zaupa C, et al. (2009) Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors. Cancer Res 69: 3472-81.
-
(2009)
Cancer Res
, vol.69
, pp. 3472-3481
-
-
Wakimoto, H.1
Kesari, S.2
Farrell, C.J.3
Curry Jr., W.T.4
Zaupa, C.5
-
37
-
-
0032530482
-
Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase
-
Delcommenne M, Tan C, Gray V, Rue L, Woodgett J, et al. (1998) Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci U S A 95: 11211-6.
-
(1998)
Proc Natl Acad Sci U S A
, vol.95
, pp. 11211-11216
-
-
Delcommenne, M.1
Tan, C.2
Gray, V.3
Rue, L.4
Woodgett, J.5
-
38
-
-
31544439674
-
Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survival
-
Troussard AA, McDonald PC, Wederell ED, Mawji NM, Filipenko NR, et al. (2006) Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survival. Cancer Res 66: 393-403.
-
(2006)
Cancer Res
, vol.66
, pp. 393-403
-
-
Troussard, A.A.1
McDonald, P.C.2
Wederell, E.D.3
Mawji, N.M.4
Filipenko, N.R.5
-
39
-
-
19944411156
-
Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth
-
Edwards LA, Thiessen B, Dragowska WH, Daynard T, Bally MB, et al. (2005) Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth. Oncogene 24: 3596-605.
-
(2005)
Oncogene
, vol.24
, pp. 3596-3605
-
-
Edwards, L.A.1
Thiessen, B.2
Dragowska, W.H.3
Daynard, T.4
Bally, M.B.5
-
40
-
-
0034895056
-
Combined targeting of adenoviruses to integrins and epidermal growth factor receptors increases gene transfer into primary glioma cells and spheroids
-
Grill J, Van Beusechem VW, Van Der Valk P, Dirven CM, Leonhart A, et al. (2001) Combined targeting of adenoviruses to integrins and epidermal growth factor receptors increases gene transfer into primary glioma cells and spheroids. Clin Cancer Res 7: 641-50.
-
(2001)
Clin Cancer Res
, vol.7
, pp. 641-650
-
-
Grill, J.1
Van Beusechem, V.W.2
Van Der Valk, P.3
Dirven, C.M.4
Leonhart, A.5
-
41
-
-
34547637424
-
Visualizing the dynamics of EGFR activity and antiglioma therapies in vivo
-
Arwert E, Hingtgen S, Figueiredo JL, Bergquist H, Mahmood U, et al. (2007) Visualizing the dynamics of EGFR activity and antiglioma therapies in vivo. Cancer Res 67: 7335-42.
-
(2007)
Cancer Res
, vol.67
, pp. 7335-7342
-
-
Arwert, E.1
Hingtgen, S.2
Figueiredo, J.L.3
Bergquist, H.4
Mahmood, U.5
-
42
-
-
33846213523
-
Retargeted oncolytic measles strains entering via the EGFRvIII receptor maintain significant antitumor activity against gliomas with increased tumor specificity
-
Allen C, Vongpunsawad S, Nakamura T, James CD, Schroeder M, et al. (2006) Retargeted oncolytic measles strains entering via the EGFRvIII receptor maintain significant antitumor activity against gliomas with increased tumor specificity. Cancer Res 66: 11840-50.
-
(2006)
Cancer Res
, vol.66
, pp. 11840-11850
-
-
Allen, C.1
Vongpunsawad, S.2
Nakamura, T.3
James, C.D.4
Schroeder, M.5
-
43
-
-
84859530282
-
Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells
-
Wakimoto H, Mohapatra G, Kanai R, Curry WT Jr, Yip S, et al. (2012) Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells. Neuro Oncol 14: 132-44.
-
(2012)
Neuro Oncol
, vol.14
, pp. 132-144
-
-
Wakimoto, H.1
Mohapatra, G.2
Kanai, R.3
Curry Jr., W.T.4
Yip, S.5
-
44
-
-
0032977124
-
Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines
-
Ishii N, Maier D, Merlo A, Tada M, Sawamura Y, et al. (1999) Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol 9: 469-79.
-
(1999)
Brain Pathol
, vol.9
, pp. 469-479
-
-
Ishii, N.1
Maier, D.2
Merlo, A.3
Tada, M.4
Sawamura, Y.5
-
45
-
-
17144398831
-
Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis
-
Lefranc F, Brotchi J, Kiss R, (2005) Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J Clin Oncol 23: 2411-22.
-
(2005)
J Clin Oncol
, vol.23
, pp. 2411-2422
-
-
Lefranc, F.1
Brotchi, J.2
Kiss, R.3
-
46
-
-
0141618355
-
EGF receptor mediates adhesion-dependent activation of the Rac GTPase: a role for phosphatidylinositol 3-kinase and Vav2
-
Marcoux N, Vuori K, (2003) EGF receptor mediates adhesion-dependent activation of the Rac GTPase: a role for phosphatidylinositol 3-kinase and Vav2. Oncogene 22: 6100-6.
-
(2003)
Oncogene
, vol.22
, pp. 6100-6106
-
-
Marcoux, N.1
Vuori, K.2
-
47
-
-
0028089832
-
Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement
-
Chen P, Xie H, Sekar MC, Gupta K, Wells A, (1994) Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement. J Cell Biol 127: 847-57.
-
(1994)
J Cell Biol
, vol.127
, pp. 847-857
-
-
Chen, P.1
Xie, H.2
Sekar, M.C.3
Gupta, K.4
Wells, A.5
-
48
-
-
47949104258
-
Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling
-
Ikenoue T, Inoki K, Yang Q, Zhou X, Guan KL, (2008) Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling. Embo J 27: 1919-31.
-
(2008)
Embo J
, vol.27
, pp. 1919-1931
-
-
Ikenoue, T.1
Inoki, K.2
Yang, Q.3
Zhou, X.4
Guan, K.L.5
-
49
-
-
47949125486
-
The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C
-
Facchinetti V, Ouyang W, Wei H, Soto N, Lazorchak A, et al. (2008) The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C. Embo J. 27: 1932-43.
-
(2008)
Embo J
, vol.27
, pp. 1932-1943
-
-
Facchinetti, V.1
Ouyang, W.2
Wei, H.3
Soto, N.4
Lazorchak, A.5
-
50
-
-
33751348056
-
Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1
-
Guertin DA, Stevens DM, Thoreen CC, Burds AA, Kalaany NY, et al. (2006) Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. Dev Cell 11: 859-71.
-
(2006)
Dev Cell
, vol.11
, pp. 859-871
-
-
Guertin, D.A.1
Stevens, D.M.2
Thoreen, C.C.3
Burds, A.A.4
Kalaany, N.Y.5
-
51
-
-
0032825702
-
The role of protein kinase Calpha in U-87 glioma invasion
-
Cho KK, Mikkelsen T, Lee YJ, Jiang F, Chopp M, et al. (1999) The role of protein kinase Calpha in U-87 glioma invasion. Int J Dev Neurosci 17: 447-61.
-
(1999)
Int J Dev Neurosci
, vol.17
, pp. 447-461
-
-
Cho, K.K.1
Mikkelsen, T.2
Lee, Y.J.3
Jiang, F.4
Chopp, M.5
-
52
-
-
61849087971
-
Reduction of protein kinase C zeta inhibits migration and invasion of human glioblastoma cells
-
Guo H, Gu F, Li W, Zhang B, Niu R, et al. (2009) Reduction of protein kinase C zeta inhibits migration and invasion of human glioblastoma cells. J Neurochem 109: 203-13.
-
(2009)
J Neurochem
, vol.109
, pp. 203-213
-
-
Guo, H.1
Gu, F.2
Li, W.3
Zhang, B.4
Niu, R.5
-
53
-
-
16544370071
-
Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
-
Brandes AA, Tosoni A, Basso U, Reni M, Valduga F, et al. (2004) Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO). J Clin Oncol 22: 4779-86.
-
(2004)
J Clin Oncol
, vol.22
, pp. 4779-4786
-
-
Brandes, A.A.1
Tosoni, A.2
Basso, U.3
Reni, M.4
Valduga, F.5
-
54
-
-
18344374653
-
Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience
-
Turner CD, Gururangan S, Eastwood J, Bottom K, Watral M, et al. (2002) Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience. Neuro Oncol 4: 102-8.
-
(2002)
Neuro Oncol
, vol.4
, pp. 102-108
-
-
Turner, C.D.1
Gururangan, S.2
Eastwood, J.3
Bottom, K.4
Watral, M.5
-
55
-
-
0035830431
-
PCV chemotherapy for recurrent glioblastoma multiforme
-
Kappelle AC, Postma TJ, Taphoorn MJ, Groeneveld GJ, van den Bent MJ, et al. (2001) PCV chemotherapy for recurrent glioblastoma multiforme. Neurology 56: 118-20.
-
(2001)
Neurology
, vol.56
, pp. 118-120
-
-
Kappelle, A.C.1
Postma, T.J.2
Taphoorn, M.J.3
Groeneveld, G.J.4
van den Bent, M.J.5
-
56
-
-
77749338221
-
Recent advances in therapy for glioblastoma
-
Clarke J, Butowski N, Chang S, (2010) Recent advances in therapy for glioblastoma. Arch Neurol 67: 279-83.
-
(2010)
Arch Neurol
, vol.67
, pp. 279-283
-
-
Clarke, J.1
Butowski, N.2
Chang, S.3
-
57
-
-
58649092475
-
mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1)
-
Garcia-Martinez JM, Alessi DR, (2008) mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). Biochem J 416: 375-85.
-
(2008)
Biochem J
, vol.416
, pp. 375-385
-
-
Garcia-Martinez, J.M.1
Alessi, D.R.2
-
58
-
-
28944448745
-
ZD6474 inhibits tumor growth and intraperitoneal dissemination in a highly metastatic orthotopic gastric cancer model
-
Arao T, Yanagihara K, Takigahira M, Takeda M, Koizumi F, et al. (2006) ZD6474 inhibits tumor growth and intraperitoneal dissemination in a highly metastatic orthotopic gastric cancer model. Int J Cancer 118: 483-9.
-
(2006)
Int J Cancer
, vol.118
, pp. 483-489
-
-
Arao, T.1
Yanagihara, K.2
Takigahira, M.3
Takeda, M.4
Koizumi, F.5
-
59
-
-
23944453425
-
Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study
-
Galanis E, Buckner JC, Maurer MJ, Kreisberg JI, Ballman K, et al. (2005) Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study. J Clin Oncol 23: 5294-304.
-
(2005)
J Clin Oncol
, vol.23
, pp. 5294-5304
-
-
Galanis, E.1
Buckner, J.C.2
Maurer, M.J.3
Kreisberg, J.I.4
Ballman, K.5
-
60
-
-
21044431575
-
Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme
-
Chang SM, Wen P, Cloughesy T, Greenberg H, Schiff D, et al. (2005) Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme. Invest New Drugs 23: 357-61.
-
(2005)
Invest New Drugs
, vol.23
, pp. 357-361
-
-
Chang, S.M.1
Wen, P.2
Cloughesy, T.3
Greenberg, H.4
Schiff, D.5
-
61
-
-
1842500007
-
Phase II trial of gefitinib in recurrent glioblastoma
-
Rich JN, Reardon DA, Peery T, Dowell JM, Quinn JA, et al. (2004) Phase II trial of gefitinib in recurrent glioblastoma. J Clin Oncol 22: 133-42.
-
(2004)
J Clin Oncol
, vol.22
, pp. 133-142
-
-
Rich, J.N.1
Reardon, D.A.2
Peery, T.3
Dowell, J.M.4
Quinn, J.A.5
-
62
-
-
75749122223
-
A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy
-
Raizer JJ, Abrey LE, Lassman AB, Chang SM, Lamborn KR, et al. (2010) A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy. Neuro Oncol 12: 95-103.
-
(2010)
Neuro Oncol
, vol.12
, pp. 95-103
-
-
Raizer, J.J.1
Abrey, L.E.2
Lassman, A.B.3
Chang, S.M.4
Lamborn, K.R.5
-
63
-
-
78049306732
-
Safety and efficacy of erlotinib in first-relapse glioblastoma: a phase II open-label study
-
Yung WK, Vredenburgh JJ, Cloughesy TF, Nghiemphu P, Klencke B, et al. (2010) Safety and efficacy of erlotinib in first-relapse glioblastoma: a phase II open-label study. Neuro Oncol 12: 1061-70.
-
(2010)
Neuro Oncol
, vol.12
, pp. 1061-1070
-
-
Yung, W.K.1
Vredenburgh, J.J.2
Cloughesy, T.F.3
Nghiemphu, P.4
Klencke, B.5
-
64
-
-
75049084471
-
Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma
-
Reardon DA, Desjardins A, Vredenburgh JJ, Gururangan S, Friedman AH, et al. (2010) Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma. J Neurooncol 96: 219-30.
-
(2010)
J Neurooncol
, vol.96
, pp. 219-230
-
-
Reardon, D.A.1
Desjardins, A.2
Vredenburgh, J.J.3
Gururangan, S.4
Friedman, A.H.5
-
65
-
-
59349089499
-
A pilot study of everolimus and gefitinib in the treatment of recurrent glioblastoma (GBM)
-
Kreisl TN, Lassman AB, Mischel PS, Rosen N, Scher HI, et al. (2009) A pilot study of everolimus and gefitinib in the treatment of recurrent glioblastoma (GBM). J Neurooncol 92: 99-105.
-
(2009)
J Neurooncol
, vol.92
, pp. 99-105
-
-
Kreisl, T.N.1
Lassman, A.B.2
Mischel, P.S.3
Rosen, N.4
Scher, H.I.5
-
66
-
-
69949106925
-
The double-edged sword of autophagy modulation in cancer
-
White E, DiPaola RS, (2009) The double-edged sword of autophagy modulation in cancer. Clin Cancer Res 15: 5308-16.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 5308-5316
-
-
White, E.1
DiPaola, R.S.2
-
67
-
-
4644359805
-
Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase
-
Feng J, Park J, Cron P, Hess D, Hemmings BA, (2004) Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase. J Biol Chem 279: 41189-96.
-
(2004)
J Biol Chem
, vol.279
, pp. 41189-41196
-
-
Feng, J.1
Park, J.2
Cron, P.3
Hess, D.4
Hemmings, B.A.5
-
68
-
-
2442562698
-
Regulation of protein kinase B/Akt activity and Ser473 phosphorylation by protein kinase Calpha in endothelial cells
-
Partovian C, Simons M, (2004) Regulation of protein kinase B/Akt activity and Ser473 phosphorylation by protein kinase Calpha in endothelial cells. Cell Signal 16: 951-7.
-
(2004)
Cell Signal
, vol.16
, pp. 951-957
-
-
Partovian, C.1
Simons, M.2
-
69
-
-
0033594480
-
PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2
-
Balendran A, Casamayor A, Deak M, Paterson A, Gaffney P, et al. (1999) PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2. Curr Biol 9: 393-404.
-
(1999)
Curr Biol
, vol.9
, pp. 393-404
-
-
Balendran, A.1
Casamayor, A.2
Deak, M.3
Paterson, A.4
Gaffney, P.5
-
70
-
-
0034708482
-
Akt/protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site
-
Toker A, Newton AC, (2000) Akt/protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site. J Biol Chem 275: 8271-4.
-
(2000)
J Biol Chem
, vol.275
, pp. 8271-8274
-
-
Toker, A.1
Newton, A.C.2
-
71
-
-
79955731315
-
Rictor regulates MMP-9 activity and invasion through Raf-1-MEK-ERK signaling pathway in glioma cells
-
Das G, Shiras A, Shanmuganandam K, Shastry P, (2011) Rictor regulates MMP-9 activity and invasion through Raf-1-MEK-ERK signaling pathway in glioma cells. Mol Carcinog 50: 412-23.
-
(2011)
Mol Carcinog
, vol.50
, pp. 412-423
-
-
Das, G.1
Shiras, A.2
Shanmuganandam, K.3
Shastry, P.4
-
72
-
-
0036855463
-
Protein kinase C alpha (PKC alpha): regulation and biological function
-
Nakashima S, (2002) Protein kinase C alpha (PKC alpha): regulation and biological function. J Biochem 132: 669-75.
-
(2002)
J Biochem
, vol.132
, pp. 669-675
-
-
Nakashima, S.1
-
74
-
-
34247218483
-
Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
-
Franceschi E, Cavallo G, Lonardi S, Magrini E, Tosoni A, et al. (2007) Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO). Br J Cancer 96: 1047-51.
-
(2007)
Br J Cancer
, vol.96
, pp. 1047-1051
-
-
Franceschi, E.1
Cavallo, G.2
Lonardi, S.3
Magrini, E.4
Tosoni, A.5
-
75
-
-
50649103493
-
Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma
-
de Groot JF, Gilbert MR, Aldape K, Hess KR, Hanna TA, et al. (2008) Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma. J Neurooncol 90: 89-97.
-
(2008)
J Neurooncol
, vol.90
, pp. 89-97
-
-
de Groot, J.F.1
Gilbert, M.R.2
Aldape, K.3
Hess, K.R.4
Hanna, T.A.5
-
76
-
-
79952111297
-
Targeting the RTK-PI3K-mTOR axis in malignant glioma: overcoming resistance
-
Fan QW, Weiss WA, (2010) Targeting the RTK-PI3K-mTOR axis in malignant glioma: overcoming resistance. Curr Top Microbiol Immunol 347: 279-96.
-
(2010)
Curr Top Microbiol Immunol
, vol.347
, pp. 279-296
-
-
Fan, Q.W.1
Weiss, W.A.2
-
77
-
-
33747099671
-
Effective silencing of EGFR with RNAi demonstrates non-EGFR dependent proliferation of glioma cells
-
Vollmann A, Vornlocher HP, Stempfl T, Brockhoff G, Apfel R, et al. (2006) Effective silencing of EGFR with RNAi demonstrates non-EGFR dependent proliferation of glioma cells. Int J Oncol 28: 1531-42.
-
(2006)
Int J Oncol
, vol.28
, pp. 1531-1542
-
-
Vollmann, A.1
Vornlocher, H.P.2
Stempfl, T.3
Brockhoff, G.4
Apfel, R.5
-
78
-
-
0346690261
-
Combinatorial efficacy achieved through two-point blockade within a signaling pathway-a chemical genetic approach
-
Fan QW, Specht KM, Zhang C, Goldenberg DD, Shokat KM, et al. (2003) Combinatorial efficacy achieved through two-point blockade within a signaling pathway-a chemical genetic approach. Cancer Res 63: 8930-8.
-
(2003)
Cancer Res
, vol.63
, pp. 8930-8938
-
-
Fan, Q.W.1
Specht, K.M.2
Zhang, C.3
Goldenberg, D.D.4
Shokat, K.M.5
-
79
-
-
33748058820
-
Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN-intact glioblastoma cells
-
Wang MY, Lu KV, Zhu S, Dia EQ, Vivanco I, et al. (2006) Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN-intact glioblastoma cells. Cancer Res 66: 7864-9.
-
(2006)
Cancer Res
, vol.66
, pp. 7864-7869
-
-
Wang, M.Y.1
Lu, K.V.2
Zhu, S.3
Dia, E.Q.4
Vivanco, I.5
-
80
-
-
33644877965
-
Disruption of parallel and converging signaling pathways contributes to the synergistic antitumor effects of simultaneous mTOR and EGFR inhibition in GBM cells
-
Rao RD, Mladek AC, Lamont JD, Goble JM, Erlichman C, et al. (2005) Disruption of parallel and converging signaling pathways contributes to the synergistic antitumor effects of simultaneous mTOR and EGFR inhibition in GBM cells. Neoplasia 7: 921-9.
-
(2005)
Neoplasia
, vol.7
, pp. 921-929
-
-
Rao, R.D.1
Mladek, A.C.2
Lamont, J.D.3
Goble, J.M.4
Erlichman, C.5
-
81
-
-
33645878924
-
Suppression of EGFR expression by antisense or small interference RNA inhibits U251 glioma cell growth in vitro and in vivo
-
Kang CS, Zhang ZY, Jia ZF, Wang GX, Qiu MZ, et al. (2006) Suppression of EGFR expression by antisense or small interference RNA inhibits U251 glioma cell growth in vitro and in vivo. Cancer Gene Ther 13: 530-8.
-
(2006)
Cancer Gene Ther
, vol.13
, pp. 530-538
-
-
Kang, C.S.1
Zhang, Z.Y.2
Jia, Z.F.3
Wang, G.X.4
Qiu, M.Z.5
-
82
-
-
0031752773
-
Antisense epidermal growth factor receptor RNA transfection in human malignant glioma cells leads to inhibition of proliferation and induction of differentiation
-
Tian XX, Lam PY, Chen J, Pang JC, To SS, et al. (1998) Antisense epidermal growth factor receptor RNA transfection in human malignant glioma cells leads to inhibition of proliferation and induction of differentiation. Neuropathol Appl Neurobiol 24: 389-96.
-
(1998)
Neuropathol Appl Neurobiol
, vol.24
, pp. 389-396
-
-
Tian, X.X.1
Lam, P.Y.2
Chen, J.3
Pang, J.C.4
To, S.S.5
-
83
-
-
27744519930
-
Herpes simplex virus 1 amplicon vector-mediated siRNA targeting epidermal growth factor receptor inhibits growth of human glioma cells in vivo
-
Saydam O, Glauser DL, Heid I, Turkeri G, Hilbe M, et al. (2005) Herpes simplex virus 1 amplicon vector-mediated siRNA targeting epidermal growth factor receptor inhibits growth of human glioma cells in vivo. Mol Ther 12: 803-12.
-
(2005)
Mol Ther
, vol.12
, pp. 803-812
-
-
Saydam, O.1
Glauser, D.L.2
Heid, I.3
Turkeri, G.4
Hilbe, M.5
-
84
-
-
0036141447
-
Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling
-
Chakravarti A, Loeffler JS, Dyson NJ, (2002) Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling. Cancer Res 62: 200-7.
-
(2002)
Cancer Res
, vol.62
, pp. 200-207
-
-
Chakravarti, A.1
Loeffler, J.S.2
Dyson, N.J.3
-
85
-
-
72449198117
-
The role of MET activation in determining the sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors
-
Rho JK, Choi YJ, Lee JK, Ryoo BY, Na II, et al. (2009) The role of MET activation in determining the sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors. Mol Cancer Res 7: 1736-43.
-
(2009)
Mol Cancer Res
, vol.7
, pp. 1736-1743
-
-
Rho, J.K.1
Choi, Y.J.2
Lee, J.K.3
Ryoo, B.Y.4
Na, I.I.5
-
86
-
-
7444231680
-
RNA interference reveals that ligand-independent met activity is required for tumor cell signaling and survival
-
Shinomiya N, Gao CF, Xie Q, Gustafson M, Waters DJ, et al. (2004) RNA interference reveals that ligand-independent met activity is required for tumor cell signaling and survival. Cancer Res 64: 7962-70.
-
(2004)
Cancer Res
, vol.64
, pp. 7962-7970
-
-
Shinomiya, N.1
Gao, C.F.2
Xie, Q.3
Gustafson, M.4
Waters, D.J.5
-
87
-
-
3042673613
-
Molecular biology of gliomas
-
Lassman AB, (2004) Molecular biology of gliomas. Curr Neurol Neurosci Rep 4: 228-33.
-
(2004)
Curr Neurol Neurosci Rep
, vol.4
, pp. 228-233
-
-
Lassman, A.B.1
-
88
-
-
0141542627
-
Distinct mechanisms mediate the initial and sustained phases of cell migration in epidermal growth factor receptor-overexpressing cells
-
Kruger JS, Reddy KB, (2003) Distinct mechanisms mediate the initial and sustained phases of cell migration in epidermal growth factor receptor-overexpressing cells. Mol Cancer Res 1: 801-9.
-
(2003)
Mol Cancer Res
, vol.1
, pp. 801-809
-
-
Kruger, J.S.1
Reddy, K.B.2
-
89
-
-
84860816141
-
Oncogenic EGFR signaling activates an mTORC2-NF-kappaB pathway that promotes chemotherapy resistance
-
Tanaka K, Babic I, Nathanson D, Akhavan D, Guo D, et al. (2011) Oncogenic EGFR signaling activates an mTORC2-NF-kappaB pathway that promotes chemotherapy resistance. Cancer Discov 1: 524-38.
-
(2011)
Cancer Discov
, vol.1
, pp. 524-538
-
-
Tanaka, K.1
Babic, I.2
Nathanson, D.3
Akhavan, D.4
Guo, D.5
-
90
-
-
70349974841
-
The pyridinylfuranopyrimidine inhibitor, PI-103, chemosensitizes glioblastoma cells for apoptosis by inhibiting DNA repair
-
Westhoff MA, Kandenwein JA, Karl S, Vellanki SH, Braun V, et al. (2009) The pyridinylfuranopyrimidine inhibitor, PI-103, chemosensitizes glioblastoma cells for apoptosis by inhibiting DNA repair. Oncogene 28: 3586-96.
-
(2009)
Oncogene
, vol.28
, pp. 3586-3596
-
-
Westhoff, M.A.1
Kandenwein, J.A.2
Karl, S.3
Vellanki, S.H.4
Braun, V.5
-
91
-
-
77954341696
-
Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics
-
Krakstad C, Chekenya M, (2010) Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics. Mol Cancer 9: 135.
-
(2010)
Mol Cancer
, vol.9
, pp. 135
-
-
Krakstad, C.1
Chekenya, M.2
-
92
-
-
34547410311
-
Cellular responses to EGFR inhibitors and their relevance to cancer therapy
-
Dutta PR, Maity A, (2007) Cellular responses to EGFR inhibitors and their relevance to cancer therapy. Cancer Lett 254: 165-77.
-
(2007)
Cancer Lett
, vol.254
, pp. 165-177
-
-
Dutta, P.R.1
Maity, A.2
-
93
-
-
52749087584
-
Brain tumour stem cells: implications for cancer therapy and regenerative medicine
-
Sanchez-Martin M, (2008) Brain tumour stem cells: implications for cancer therapy and regenerative medicine. Curr Stem Cell Res Ther 3: 197-207.
-
(2008)
Curr Stem Cell Res Ther
, vol.3
, pp. 197-207
-
-
Sanchez-Martin, M.1
-
94
-
-
58749089674
-
The postoperative brain tumour stem cell (BTSC) niche and cancer recurrence
-
Liu JM, Mao BY, Hong S, Liu YH, Wang XJ, (2008) The postoperative brain tumour stem cell (BTSC) niche and cancer recurrence. Adv Ther 25: 389-98.
-
(2008)
Adv Ther
, vol.25
, pp. 389-398
-
-
Liu, J.M.1
Mao, B.Y.2
Hong, S.3
Liu, Y.H.4
Wang, X.J.5
|